Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial
在类风湿性关节炎患者病情缓解后,采用递增剂量策略持续停用英夫利昔单抗:RRRR 研究,一项随机对照试验
期刊:Annals of the Rheumatic Diseases
影响因子:20.6
doi:10.1136/annrheumdis-2019-216169
Tanaka, Yoshiya; Oba, Koji; Koike, Takao; Miyasaka, Nobuyuki; Mimori, Tsuneyo; Takeuchi, Tsutomu; Hirata, Shintaro; Tanaka, Eiichi; Yasuoka, Hidekata; Kaneko, Yuko; Murakami, Kosaku; Koga, Tomohiro; Nakano, Kazuhisa; Amano, Koichi; Ushio, Kazuyasu; Atsumi, Tatsuya; Inoo, Masayuki; Hatta, Kazuhiro; Mizuki, Shinichi; Nagaoka, Shouhei; Tsunoda, Shinichiro; Dobashi, Hiroaki; Horie, Nao; Sato, Norihiro